205
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Health-related quality of life and long-term symptoms among patients with non-severe covid-19 – a prospective cohort study

ORCID Icon, , , , & ORCID Icon
Pages 272-281 | Received 12 Jun 2022, Accepted 29 Jan 2023, Published online: 08 Feb 2023

References

  • World Health Organization. [cited 2022 Jun 1]. Available from: https://covid19.who.int/
  • Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013–1022.
  • Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4–e6.
  • Guan WJ, Ni ZY, Hu Y, China Medical Treatment Expert Group for Covid-19, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242.
  • Meys R, Delbressine JM, Goertz YMJ, et al. Generic and respiratory-specific quality of life in non-hospitalized patients with COVID-19. J Clin Med. 2020;9(12):3993.
  • Fisher KA, Olson SM, Tenforde MW, et al. Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza Other Respir Viruses. 2021;15(3):345–351.
  • van den Borst B, Peters JB, Brink M, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2021;73(5):e1089–e1098.
  • Cameron B, Bharadwaj M, Burrows J, et al. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis. 2006;193(5):664–671.
  • Tiga-Loza DC, Martinez-Vega RA, Undurraga EA, et al. Persistence of symptoms in dengue patients: a clinical cohort study. Trans R Soc Trop Med Hyg. 2020;114(5):355–364.
  • Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12):ofaa509.
  • Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93–135.
  • Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-a systematic review and meta-analysis. J Med Virol. 2022;94(1):253–262.
  • Lemhöfer C, Sturm C, Loudovici-Krug D, et al. The impact of Post-COVID-syndrome on functioning - results from a community survey in patients after mild and moderate SARS-CoV-2-infections in Germany. J Occup Med Toxicol. 2021;16(1):45.
  • Lund LC, Hallas J, Nielsen H, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021;21(10):1373–1382.
  • O'Keefe JB, Minton HC, Morrow M, et al. Postacute sequelae of SARS-CoV-2 infection and impact on quality of life 1-6 months after illness and association with initial symptom severity. Open Forum Infect Dis. 2021;8(8):ofab352.
  • Anjana NKN, Annie TT, Siba S, et al. Manifestations and risk factors of post COVID syndrome among COVID-19 patients presented with minimal symptoms – a study from Kerala, India. J Family Med Prim Care. 2021;10(11):4023–4029.
  • Jennifer K Logue NMF, McCulloch DJ, McDonald D, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830.
  • Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.
  • Stavem K, Ghanima W, Olsen MK, et al. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405–407.
  • Blomberg B, Mohn KG, Brokstad KA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607–1613.
  • Boscolo-Rizzo P, Guida F, Polesel J, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021;11(12):1685–1688.
  • Peghin M, Palese A, Venturini M, et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507–1513.
  • Burstrom K, Sun S, Gerdtham UG, et al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–442.
  • Emilsson M, Berndtsson I, Gustafsson PA, et al. Reliability and validation of swedish translation of beliefs about medication specific (BMQ-Specific) and brief illness perception questionnaire (B-IPQ) for use in adolescents with attention-deficit hyperactivity disorder. Nord J Psychiatry. 2020;74(2):89–95.
  • EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
  • van Reenen M, Oppe M, Boye KS, et al. EQ-5D-3L UserGuide. EuroQol Research Foundation; 2018. Available from: https://euroqol.org/publications/user-guides
  • Broadbent E, Petrie KJ, Main J, et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637.
  • van Kessel SAM, Olde Hartman TC, Lucassen P, et al. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159–167.
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. The Lancet. 2020;395(10223):497–506.
  • Taquet M, Dercon Q, Luciano S, et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLOS Med. 2021;18(9):e1003773.
  • Desgranges F, Tadini E, Munting A, et al. Post‑COVID‑19 syndrome in outpatients: a cohort study. J Gen Intern Med. 2022;37(8):1943–1952.
  • Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631.
  • Ballering AV, van Zon SKR, Olde Hartman TC, et al. Lifelines corona research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452–461.
  • Carenzo L, Protti A, Dalla Corte F, et al. Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19. Ann Intensive Care. 2021;11(1):91.
  • Walle-Hansen MM, Ranhoff AH, Mellingsæter M, et al. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021;21(1):199.
  • Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882.
  • Larsson SB, von Feilitzen GS, Andersson ME, et al. Self-reported symptom severity, general health, and impairment in post-acute phases of COVID-19: retrospective cohort study of swedish public employees. Sci Rep. 2022;12(1):19818.
  • Westerlind E, Palstam A, Sunnerhagen KS, et al. Patterns and predictors of sick leave after covid-19 and long covid in a national swedish cohort. BMC Public Health. 2021;21(1):1023.
  • Huynh G, Nguyen BT, Nguyen HTN, et al. Health-related quality of life among patients recovered from COVID-19. Inquiry. 2022;59:469580221143630.
  • Hay JW, Gong CL, Jiao X, et al. A US population health survey on the impact of COVID-19 using the EQ-5D-5L. J Gen Intern Med. 2021;36(5):1292–1301.
  • Ullah S, Ali S, Daud M, et al. Illness perception about hepatitis C virus infection: a cross-sectional study from Khyber Pakhtunkhwa Pakistan. BMC Infect Dis. 2022;22(1):74.
  • Shim EJ, Jeong D, Song YW, et al. A network analysis of the brief illness perception questionnaire in patients with rheumatic diseases and human immunodeficiency virus infection. Psychol Health. 2020;35(7):838–853.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.